Dark Forest Capital Management’s Myriad Genetics MYGN Stock Holding History

Dark Forest Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,764	Closed	-$92.3K	–	1217
2025 Q3	$92.3K	Sell	12,764 -43,608	-77%	-$259K	﹤0.01%	1100
2025 Q2	$299K	Buy	+56,372	New	+$333K	0.01%	1028
2022 Q4	–	Sell	-504	Closed	-$10K	–	1374
2022 Q3	$10K	Buy	+504	New	+$11.6K	﹤0.01%	744
2022 Q2	–	Sell	-309	Closed	-$8K	–	1205
2022 Q1	$8K	Sell	309 -92	-23%	-$2.35K	﹤0.01%	1041
2021 Q4	$11K	Buy	+401	New	+$11.6K	﹤0.01%	892

Other funds holding MYGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dark Forest Capital Management's MYGN Position: Q4 2025 in Review

Dark Forest Capital Management sold out of Myriad Genetics (MYGN) in Q4 2025, closing a stake of 12,764 shares — an estimated $92.3K sold.

Dark Forest Capital Management first reported a position in MYGN in Q4 2021 and held it in 5 quarters. The position peaked at $299K in Q2 2025. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2025.

Dark Forest Capital Management reported no remaining Myriad Genetics position as of Q4 2025 after selling out during the quarter.
Dark Forest Capital Management sold 12,764 Myriad Genetics shares in Q4 2025, an estimated $92.3K.
Dark Forest Capital Management first reported a position in Myriad Genetics in Q4 2021 and held it in 5 quarters.
Dark Forest Capital Management's Myriad Genetics position peaked at $299K in Q2 2025.
221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2025.

Based on Dark Forest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.